New business models for pharmaceutical research and development as a global public good considerations for the WHO European Region

Public concern has been increasing about the high prices of novel medicines, limits on availability and access, and the strain on health-care budgets across all countries. Addressing these challenges requires scrutinizing the underlying system of research and development (R&D) that produces thes...

Full description

Bibliographic Details
Main Authors: Moon, Suerie, Vieira, Marcela (Author), Alonso Ruiz, Adrián (Author), Navarro, Danielle (Author)
Corporate Authors: Oslo Medicines Initiative, World Health Organization Regional Office for Europe
Format: eBook
Language:English
Published: Copenhagen, Denmark World Health Organization 2022, [2022]
Series:Oslo medicines initiative technical report
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references